English 
Français 
Русский 
Español 
Deutsch 
Português 
العربية 
Italiano Partnering for Health Equity: Ozelle and Local Collaborators Reshape Diagnostics Across Indonesia
——EHBT-50 Mini Lab Launches with Strong Market Reception
Jakarta, September 24, 2025 — Ozelle officially launched its EHBT-50 Mini Lab Multi-Functional Analyzer (EHBT-50 Mini Lab) in Indonesia today, marking a key milestone in bringing advanced diagnostics into frontline clinics and everyday medical practice. The launch event, initiated and organized by Ozelle’s local partner, brought together healthcare professionals and industry leaders to experience the future of diagnostics. Ozelle also announced that it will showcase its AI-powered solutions at the Indonesia Int’l Hospital Expo (Booth: Hall 2, 365; 25–28 September 2025), Indonesia’s leading and most influential healthcare exhibition, inviting attendees to explore the solutions firsthand.
Rising Market Demand and Opportunity
Indonesia’s healthcare system is growing rapidly, yet smaller clinics and community-level facilities still lack access to advanced diagnostics. This gap creates an urgent need for solutions that are more accurate, efficient, and accessible. The EHBT-50 Mini Lab directly addresses this gap, offering comprehensive capabilities once limited to major hospitals.
Transforming Diagnostics with AI + Complete Blood Morphology
At the heart of the EHBT-50 Mini Lab is Ozelle’s AI-powered Complete Blood Morphology (CBM), a breakthrough integration of Complete Blood Count and Peripheral Blood Smear. Traditional workflows depend on manual smears and microscopic review, but CBM automates every step—from preparation to AI-driven analysis—delivering reliable results without human bias.
This innovation empowers medical practice to achieve advanced diagnostics with ease. Attendees shared their impressions at the event:
-
“The automation helps reduce errors and speeds up decision-making,” said Dr.Rina, hematologist.
-
“It’s exciting to see advanced diagnostics reaching communities that previously had limited access—this can make a difference,” noted Michael, regional clinic director.
Key Highlights
-
AI-Powered Smarter Diagnosis: Accurately identifies abnormal and multi-classified blood cells beyond 7-diff and an AI engine that supports earlier, more precise clinical decisions.
-
All-in-One Testing: Integrates hematology, immunoassay, and biochemistry analysis in one device—optimizing space, cost, and workflow.
-
Fully Automated, High Efficiency: Delivers results from sample to report in six minutes, eliminating manual handling.
-
Innovative Cost-Saving Consumables: Single-use cartridges with room-temperature storage and a maintenance-free dry system prevent contamination, simplify logistics, and reduce costs.
-
Advanced Diagnostics Designed for Primary Care: easy to set up, maintenance-free, and scalable.
Partner Support & Next Steps The event showed strong partner confidence in the EHBT-50 Mini Lab’s clinical value and market potential. “Strong interest from clinicians proves its ability to raise standards and expand access,” said Ozelle’s local partner. “Together with local collaborators, we aim not only to bring innovations but to enhance diagnostic services in Indonesia,” said Luke, spokesperson for Ozelle. “This launch is just the beginning—we invite you to meet us at the Indonesia Int’l Hospital Expo, where we will showcase how AI-powered diagnostics can benefit more communities.”
